References
- The CONSENSUS Trial Study Group . Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS) . N. Engl. J. Med.316 ( 23 ), 1429 – 1435 ( 1987 ).
- McMurray JJ , PackerM, DesaiASet al. Angiotensin–neprilysin inhibition versus enalapril in heart failure . N. Engl. J. Med.371 ( 11 ), 993 – 1004 ( 2014 ).
- Kober L , ThuneJJ, NielsonJCet al. Defibrillator implantation in patients with nonischaemic systolic heart failure . N. Engl. J. Med.375 ( 13 ), 1221 – 1230 ( 2016 ).
- Elming MB , NielsonJC, VidebaekLet al. Age and outcomes of primary prevention implantable cardioverter-defibrillators in patients with nonischemic systolic heart failure . Circulation136 ( 19 ), 1772 – 1780 ( 2017 ).
- Petrie MC , JhundPS, SheLet al. Ten-year outcomes after coronary artery bypass grafting according to age in patients with heart failure and left ventricular systolic dysfunction . Circulation134 ( 18 ), 1314 – 1324 ( 2016 ).
- Mehra MR , NakaY, UrielNet al. A fully magnetically levitated circulatory pump for advanced heart failure . N. Engl. J. Med.376 ( 5 ), 440 – 450 ( 2017 ).
- Rogers JG , PaganiFD, TatoolesAJet al. Intrapericardial left ventricular assist device for advanced heart failure . N. Engl. J. Med.376 ( 5 ), 451 – 460 ( 2017 ).
- Denner J . Paving the path toward porcine organs for transplantation . N. Engl. J. Med.377 ( 19 ), 1891 – 1893 ( 2017 ).
- Packer M , O’ConnorC, McMurrayJJVet al. Effect of ularitide on cardiovascular mortality in acute heart failure . N. Engl. J. Med.376 ( 20 ), 1956 – 1964 ( 2017 ).
- Efficacy, safety and tolerability of serelaxin when added to standard therapy in AHF (RELAX-AHF 2) . ClinicalTrials.gov Identifier: NCT01870778 . https://clinicaltrials.gov/ct2/show/NCT01870778 .
- Felker GM , AnstromKJ, AdamsKJet al. Effect of natriuretic peptide-guided therapy on hospitalization or cardiovascular mortality in high-risk patients with heart failure and reduced ejection fraction: a randomized clinical trial . JAMA318 ( 8 ), 713 – 720 ( 2017 ).
- Komajda M , IsnardR, Cohen-SolalAet al. Effect of ivabradine in patients with heart failure with preserved ejection fraction: the EDIFY randomised placebo-controlled trial . Eur. J. Heart Fail.19 ( 11 ), 1495 – 1503 ( 2017 ).
- Feldman T , MauriL, KahwashRet al. A transcatheter interatrial shunt device for the treatment of heart failure with preserved ejection fraction (REDUCE LAP-HF I): a Phase II, randomized, sham-controlled trial . Circulation137 ( 6 ), 364 – 375 ( 2017 ).
- Zinman B , WannerC, LachinJMet al. Empagliflozin, cardiovascular outcomes, and mortality in Type 2 diabetes . N. Engl. J. Med.373 ( 22 ), 2117 – 2128 ( 2015 ).
- Neal B , PerkovicV, MahaffeyKet al. Canagliflozin and cardiovascular and renal events in Type 2 diabetes . N. Engl. J. Med.377 ( 7 ), 644 – 657 ( 2017 ).
- Marrouche NF , BrachmannJ, AndresenDet al. Catheter ablation for atrial fibrillation with heart failure . N. Engl. J. Med.378 ( 5 ), 417 – 427 ( 2018 ).
- Zuchinali P , SouzaGC, PimentelMet al. Short-term effects of high-dose caffeine on cardiac arrhythmias in patients with heart failure: a randomized clinical trial . JAMA Intern. Med.176 ( 12 ), 1752 – 1759 ( 2016 ).
- Conrad N , JudgeA, TranJet al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals . Lancet391, 572 – 580 ( 2018 ).